Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report

Hemophagocytic lymphohistiocytosis (HLH), is a fatal systemic hyperinflammatory syndrome. HLH may be due to immunosuppression, infections, cancer, or autoimmune diseases with fever and cytopenia. HLH which occurs in adult-onset Stills disease (AOSD) is called secondary HLH, also known as macrophage activation syndrome (MAS). Here, we present a case of a 36-year-old Nepalese female, with no known comorbidities presented with a history of fever, sore throat, multiple joint pain, fluctuating rash, hair loss, and unintentional weight loss for a month. She was hypotensive, with a high-grade fever. She had swollen eyelids, and erythematous macular rashes in the face, trunk, and extremities with the rest of the systemic examinations normal. Investigation showed leukocytosis, with anemia, and a blood smear showed neutrophilic leukocytosis. ESR/CRP and lactate dehydrogenase (LDH) were elevated, and ferritin was 38,291 ng/mL. Tropical disease screening, blood culture, viral serologies, imaging for malignancies, and autoimmune disease panels were negative. She met the diagnostic criteria for AOSD. MAS was suspected of abnormally high ferritin levels, and a bone marrow aspiration biopsy was done. She was given IV steroids with some improvement. The biopsy showed hypercellular marrow with erythroid hyperplasia, dyserythropoietic changes, and increased macrophages with phagocytic activity suggestive of MAS. She was started on dexamethasone and cyclosporine which eventually improved her condition. Several complications can arise in AOSD, around 15% of these patients can have MAS which is regarded as one of the most severe complications. With studies showing a mortality rate of more than 50% in patients of AOSD with MAS which is five times more than the mortality rate with AOSD alone, understanding this combined picture and timely aggressive treatment has a huge importance.

Authors

Institutions

Publication Details

Journal
Clinical Case Reports
Published
2025-01-01
DOI
https://doi.org/10.1002/ccr3.70128
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report

Saket Jha, Sunil Bogati
Clinical Case Reports
Autoimmune and Inflammatory Disorders Research
article

Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report

Saket Jha, Sunil Bogati
article en

Abstract

Hemophagocytic lymphohistiocytosis (HLH), is a fatal systemic hyperinflammatory syndrome. HLH may be due to immunosuppression, infections, cancer, or autoimmune diseases with fever and cytopenia. HLH which occurs in adult-onset Stills disease (AOSD) is called secondary HLH, also known as macrophage activation syndrome (MAS). Here, we present a case of a 36-year-old Nepalese female, with no known comorbidities presented with a history of fever, sore throat, multiple joint pain, fluctuating rash, hair loss, and unintentional weight loss for a month. She was hypotensive, with a high-grade fever. She had swollen eyelids, and erythematous macular rashes in the face, trunk, and extremities with the rest of the systemic examinations normal. Investigation showed leukocytosis, with anemia, and a blood smear showed neutrophilic leukocytosis. ESR/CRP and lactate dehydrogenase (LDH) were elevated, and ferritin was 38,291 ng/mL. Tropical disease screening, blood culture, viral serologies, imaging for malignancies, and autoimmune disease panels were negative. She met the diagnostic criteria for AOSD. MAS was suspected of abnormally high ferritin levels, and a bone marrow aspiration biopsy was done. She was given IV steroids with some improvement. The biopsy showed hypercellular marrow with erythroid hyperplasia, dyserythropoietic changes, and increased macrophages with phagocytic activity suggestive of MAS. She was started on dexamethasone and cyclosporine which eventually improved her condition. Several complications can arise in AOSD, around 15% of these patients can have MAS which is regarded as one of the most severe complications. With studies showing a mortality rate of more than 50% in patients of AOSD with MAS which is five times more than the mortality rate with AOSD alone, understanding this combined picture and timely aggressive treatment has a huge importance.

Clinical Case ReportsVol. 13(1)
St. Mary's Hospital (US), Tribhuvan University Teaching Hospital (NP), Nepalese Army Institute of Health Services (NP)
Good health and well-being
Openalex Percentile: Top 99%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.